Xeris Biopharma Holdings Inc (NASDAQ:XERS) 61.17% Above Its 52-Week Low, How Long Will It Keep Rising?

In last trading session, Xeris Biopharma Holdings Inc (NASDAQ:XERS) saw 1.73 million shares changing hands with its beta currently measuring 0.68. Company’s recent per share price level of $4.79 trading at $0.15 or 3.23% at ring of the bell on the day assigns it a market valuation of $767.14M. That closing price of XERS’s stock is at a discount of -26.72% from its 52-week high price of $6.07 and is indicating a premium of 61.17% from its 52-week low price of $1.86.

For Xeris Biopharma Holdings Inc (XERS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.33. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Xeris Biopharma Holdings Inc (NASDAQ:XERS) trade information

Upright in the green during last session for gaining 3.23%, in the last five days XERS remained trading in the red while hitting it’s week-highest on Friday, 05/09/25 when the stock touched $4.79 price level, adding 8.41% to its value on the day. Xeris Biopharma Holdings Inc’s shares saw a change of 41.30% in year-to-date performance and have moved -7.17% in past 5-day. Xeris Biopharma Holdings Inc (NASDAQ:XERS) showed a performance of 9.36% in past 30-days.

Wall Street analysts have assigned a consensus price target of 4 to the stock, which implies a fall of -19.75% to its current value. Analysts have been projecting 4 as a low price target for the stock while placing it at a high target of 4. It follows that stock’s current price would jump 16.49% in reaching the projected high whereas dropping to the targeted low would mean a gain of 16.49% for stock’s current value.

Xeris Biopharma Holdings Inc (NASDAQ:XERS)’s Major holders

BLACKROCK INC. is the top institutional holder at XERS for having 10.33 million shares of worth $23.25 million. And as of 2024-06-30, it was holding 6.9649 of the company’s outstanding shares.

The second largest institutional holder is VANGUARD GROUP INC, which was holding about 7.66 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.1615 of outstanding shares, having a total worth of $17.23 million.

On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024, the former fund manager was holding 4.22 shares of worth $20.22 million or 2.70% of the total outstanding shares. The later fund manager was in possession of 3.71 shares on Mar 31, 2025, making its stake of worth around $17.76 million in the company or a holder of 2.37% of company’s stock.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.